SEC Form 4 · accession 0001209191-16-157110
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel L Kisner
Director
Period of report
Dec 28, 2016
Accepted (ET)
Dec 30, 2016 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 28, 2016 | J | 2,310 | $0.00 | A | 5,455 | I | See footnote |
| Common Stock | holding | — | — | — | 4,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro rata distribution of 1,570 shares from Aberdare Partners III, L.P., of which the Reporting Person is a limited partner, and a pro rata distribution of 740 shares from Aberdare GP III, L.L.C., of which the Reporting Person is a non-managing member.
- F2Held by family trust of which the Reporting Person is a trustee.